Interrupting Liver Disease in Obesity
January 27, 2025 — A new paper this morning in Nature Medicine tells us that interrupting liver disease in obesity is possible with metabolic surgery. More specifically, in an observational study of patients with obesity and cirrhosis due to MASH, Ali Aminian and colleagues found a 72% lower risk of major complications from liver disease in patients who received […]